candesartan has been researched along with Memory Disorders in 4 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Memory Disorders: Disturbances in registering an impression, in the retention of an acquired impression, or in the recall of an impression. Memory impairments are associated with DEMENTIA; CRANIOCEREBRAL TRAUMA; ENCEPHALITIS; ALCOHOLISM (see also ALCOHOL AMNESTIC DISORDER); SCHIZOPHRENIA; and other conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Candesartan is an angiotensin II-receptor blocker and has proved neuroprotective properties." | 1.72 | Candesartan protects against d-galactose induced - Neurotoxicity and memory deficit via modulation of autophagy and oxidative stress. ( Abo-Saif, MA; Khedr, NF; Werida, RH, 2022) |
| "Candesartan (CDS) is an AT1 receptor antagonist with potential neuroprotective properties." | 1.42 | Antimanic-like activity of candesartan in mice: Possible involvement of antioxidant, anti-inflammatory and neurotrophic mechanisms. ( Berk, M; Budni, J; Carvalho, AF; Cavalcante, LM; de Lucena, DF; de Sousa, FC; de Souza Gomes, JA; de Souza, GC; Macêdo, D; Quevedo, J, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khedr, NF | 1 |
| Werida, RH | 1 |
| Abo-Saif, MA | 1 |
| de Souza Gomes, JA | 1 |
| de Souza, GC | 1 |
| Berk, M | 1 |
| Cavalcante, LM | 1 |
| de Sousa, FC | 1 |
| Budni, J | 1 |
| de Lucena, DF | 1 |
| Quevedo, J | 1 |
| Carvalho, AF | 1 |
| Macêdo, D | 1 |
| Tota, S | 2 |
| Kamat, PK | 2 |
| Awasthi, H | 1 |
| Singh, N | 1 |
| Raghubir, R | 1 |
| Nath, C | 2 |
| Hanif, K | 2 |
| Najmi, AK | 1 |
4 other studies available for candesartan and Memory Disorders
| Article | Year |
|---|---|
Candesartan protects against d-galactose induced - Neurotoxicity and memory deficit via modulation of autophagy and oxidative stress.
Topics: Animals; Autophagy; Autophagy-Related Protein 5; Beclin-1; Benzimidazoles; Biphenyl Compounds; Galac | 2022 |
Antimanic-like activity of candesartan in mice: Possible involvement of antioxidant, anti-inflammatory and neurotrophic mechanisms.
Topics: Amphetamine; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Antimanic A | 2015 |
Candesartan improves memory decline in mice: involvement of AT1 receptors in memory deficit induced by intracerebral streptozotocin.
Topics: Acetylcholinesterase; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Com | 2009 |
Role of central angiotensin receptors in scopolamine-induced impairment in memory, cerebral blood flow, and cholinergic function.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Avoidance Learning; Benzimidazoles; Biphenyl Compo | 2012 |